CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for EMD Millipore is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

EMD Millipore
290 Concord Road
Phone: (978) 715-4321p:978 715-4321 Billerica, MA  01821  United States Ticker: MILMIL
This company was Merged or Acquired on 7/15/2010.
This company ceased filing statements with the SEC on 7/26/2010.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
EMD Millipore is a life science company. The Company’s products and services are used in life science research, drug discovery, process development and drug manufacturing. Its Bioscience Division provides products and technologies to life science research and development activities. The Company’s Bioprocess Division provides products and services for pharmaceutical and biotechnology manufacturing. Millipore’s products and services are primarily used by biotechnology and pharmaceutical companies, academic institutions and research laboratories. Its Bioscience Division generated approximately 44% of the Company’s revenue in 2009. The Bioprocess Division generated approximately 56% of its revenue in 2009. On August 7, 2009, it acquired BioAnaLab Limited. On November 20, 2009, it acquired the remaining 60% ownership of its joint venture in India, the India JV. In July 2010, Merck KGaA acquired the Company.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, General Counsel, Secretary David P.Hutchinson 47 7/14/2010 7/14/2010
Chief Financial Officer, Vice President Anthony L.Mattacchione 47 7/14/2010 7/14/2010
Executive Vice President, Head of Global Operations Peter C.Kershaw 56 7/14/2010 2/1/2004
7 additional Officers and Directors records available in full report.

Business Names
Business Name
BioAnaLab Limited
Bioprocessing Corporation Limited
Celliance Lawrence, Inc.
54 additional Business Names available in full report.

General Information
Number of Employees: 6,100 (As of 12/31/2009)
Outstanding Shares: 56,234,916 (As of 5/1/2010)
Shareholders: 32,274
Stock Exchange: NYSE
Federal Tax Id: 42170233
Fax Number: (781) 533-3110
Email Address: Geoffrey_Helliwell@millipore.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 5, 2024